Clinical Trial

ANI-Guided Anesthetic Desflurane Consumption

Completed
View on ClinicalTrials.gov →
Summary
General anesthesia requires precise titration of inhaled anesthetics like desflurane and opioids like remifentanil to balance sedation, analgesia, and hemodynamic stability. The Analgesia/Nociception Index (ANI), derived from heart rate variability (HRV), quantifies parasympathetic tone to assess nociception-antinociception balance on a 0-100 scale, with lower values indicating nociceptive stress. ANI analyzes high-frequency HRV components, reflecting parasympathetic inhibition during painful stimuli, making it a reliable indicator of intraoperative nociception. Studies validate the utility of ANI in detecting nociceptive events during laparoscopic surgery. ANI-guided opioid titration reduces opioid consumption and stabilizes hemodynamics, enhancing perioperative outcomes.
Protocol Amendment History 1 change
critical Trial completed 2026-08-15
Trial Details
NCT Number NCT06982209
Lead Sponsor Wonkwang University Hospital
Conditions Postoperative Pain, General Anesthesia, Laparoscopic Cholecystectomy
Enrollment 125 participants
Start Date 2026-07-02
Primary Completion 2026-07-12 (estimated)
Study Completion 2026-08-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-14